SCHEMBL6087491

SCHEMBL6087491

CCOC(=O)Nc1ccc2cc(OC)ccc2c1C(O)C[Si](C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
HSD17B10 Q99714 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALOX15 P16050 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
KDR P35968 1/20 0.40
MTNR1B P49286 2/20 0.39
MTNR1A P48039 1/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TACR3 P29371 1/20 0.39
KDM4E B2RXH2 4/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6086928 0.78 ALDH1A1 (0.50) ALDH1A1HSD17B10MEN1KMT2AALOX15
SCHEMBL6107295 0.76 ALDH1A1 (0.44) ALDH1A1HSD17B10MEN1KMT2AALOX15
SCHEMBL2090279 0.70 CYP1A2 (0.58) ALDH1A1HSD17B10MEN1KMT2AALOX15
SCHEMBL18024095 0.70 ALDH1A1 (0.54) ALDH1A1HSD17B10MEN1KMT2AALOX15
SCHEMBL7557552 0.69 CYP1A2 (0.56) ALDH1A1HSD17B10MEN1KMT2AALOX15
SCHEMBL7410024 0.68 CYP1A2 (0.55) ALDH1A1HSD17B10MEN1KMT2AALOX15
SCHEMBL7254155 0.68 ALDH1A1 (0.54) ALDH1A1HSD17B10MEN1KMT2AALOX15
SCHEMBL3826494 0.67 CYP1A2 (0.47) ALDH1A1HSD17B10CYP1A2CYP2C9CYP2C19
SCHEMBL10715095 0.66 NLRP3 (0.54) ALDH1A1HSD17B10MEN1KMT2AALOX15
SCHEMBL29648996 0.66 NLRP3 (0.54) ALDH1A1HSD17B10MEN1KMT2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053108-B2 Indoline compounds LES LABORATOIRES SERVIER (FR) 2006-05-30 US disclosed
US-20040192736-A1 New indoline compounds LAVIELLE GILBERT (FR) 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192736-A1 New indoline compounds TPH1, HTR3A, HTR1D ALDH1A1 643/4885HSD17B10 500/4885MEN1 1004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.